618061-77-1 Usage
Description
(R)-diethyl 2-(4-(3-chloro-4-fluorophenylamino)-7-(tetrahydrofuran-3-yloxy)quinazolin-6-ylamino)-2-oxo is a complex chemical compound with a quinazoline core structure, featuring a diethyl and 3-chloro-4-fluorophenylamino substituent. (R)-diethyl 2-(4-(3-chloro-4-fluorophenylaMino)-7-(tetrahydrofuran-3-yloxy)quinazolin-6-ylaMino)-2-oxo has been of interest in the field of pharmacology due to its potential interactions with various biological targets, particularly in cancer research. Its unique chemical structure and pharmacological properties make it a promising candidate for further development and exploration in the pharmaceutical industry.
Uses
Used in Pharmaceutical Industry:
(R)-diethyl 2-(4-(3-chloro-4-fluorophenylamino)-7-(tetrahydrofuran-3-yloxy)quinazolin-6-ylamino)-2-oxo is used as a potential therapeutic agent for its interactions with various biological targets. (R)-diethyl 2-(4-(3-chloro-4-fluorophenylaMino)-7-(tetrahydrofuran-3-yloxy)quinazolin-6-ylaMino)-2-oxo's unique structure and pharmacological properties make it a candidate for further research and development in the treatment of certain diseases, particularly cancer.
Used in Cancer Research:
In the field of cancer research, (R)-diethyl 2-(4-(3-chloro-4-fluorophenylamino)-7-(tetrahydrofuran-3-yloxy)quinazolin-6-ylamino)-2-oxo is used as a compound for studying its potential as a therapeutic agent. Its interactions with biological targets may provide insights into the development of new cancer treatments and contribute to the advancement of pharmaceutical research in this area.
Check Digit Verification of cas no
The CAS Registry Mumber 618061-77-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,1,8,0,6 and 1 respectively; the second part has 2 digits, 7 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 618061-77:
(8*6)+(7*1)+(6*8)+(5*0)+(4*6)+(3*1)+(2*7)+(1*7)=151
151 % 10 = 1
So 618061-77-1 is a valid CAS Registry Number.
618061-77-1Relevant articles and documents
Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them
-
Page/Page column 5, (2008/06/13)
The present invention relates to bicyclic heterocycles of general formula wherein Ra, Rb, Rc, Rd, Re and X are defined as in claim 1, the tautomers, the stereoisomers, the mixtures thereof and the salts thereof, particularly the physiologically acceptable salts thereof with inorganic or organic acids, which have valuable pharmacological properties, particularly an inhibitory effect on signal transduction mediated by tyrosine kinases, the use thereof for treating diseases, particularly tumoral diseases and benign prostatic hyperplasia (BPH), diseases of the lungs and respiratory tract, and the preparation thereof.
